Elevating bio restructuring with the highest concentration of Ha ever achieved. Especially for men: Richer in collagen and lower in hyaluronic acid. An essential treatment to regain elasticity and hydration. Hyaluronic Acid in 3 molecular clustered hyper – concentrated synthetic exosomes with Biomimetic peptides and Bioactive growth factors
Biomimetic Peptides and Growth Factors:
Within the exosomal structure, SKINFILL BLUE contains a pool of biomimetic peptides and synthetic growth factors, designed to maximize bio-restructuring results. These include:
Additionally, a complex of acetylglutamine and folic acid has been introduced to support cellular metabolism.
Benefits :
A Unique and Innovative Concept
Synthetic exosomal structures deliver peptides and growth factors, along with ultra-low molecular weight HA dimmers.
Exosomal structures within a moisturizing and bio-stimulating matrix of medium molecular weight hyaluronic acid enhances the bio-restructuring effect.
The most highly concentrated solution is through a new R-AiNet Pro technology developed in our research laboratories. Push the boundaries in hyaluronic acid concentration.
High molecular weight hyaluronic acid, without cross-linking agents.
Indications
Designed to enhance skin quality, facial, neck, and decollete skin elasticity. May also reduce sagging and improve texture.
Stimulates cellular reproduction and metabolism through growth factors and biomimetic peptides.
Fill out the contact form, and we will send you a brochure!
All orders will be shipped via UPS. Shipping is calculated based upon the delivery zip code.
Returns are not accepted unless authorized by Promoitalia.
Promoitalia.com © 2021. All rights reserved.
Privacy & Cookies Policy
The information, pictures, descriptions and any other reported in PromoItalia Group s.p.a website about medical devices and accessories are not for an advertising nature but informative material intended for health professionals. Reference: Italian Ministry of health – “Nuove linee guida della pubblicità sanitaria concernente i dispositivi medici, dispositivi medico-diagnostici in vitro e presidi medico-chirurgici” of 28 March 2013.